Ionis Pharmaceuticals IONS Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's employee service share based compensation allocation of recognized period costs capitalized amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's employee service share based compensation allocation of recognized period costs capitalized amount?
- Ionis Pharmaceuticals (IONS) reported employee service share based compensation allocation of recognized period costs capitalized amount of $18K in Q1 2026.
- How has Ionis Pharmaceuticals's employee service share based compensation allocation of recognized period costs capitalized amount changed year-over-year?
- Ionis Pharmaceuticals's employee service share based compensation allocation of recognized period costs capitalized amount decreased by 96.3% year-over-year, from $491K to $18K.
- What does employee service share based compensation allocation of recognized period costs capitalized amount mean?
- The amount of stock-based pay costs added to the value of assets instead of being recorded as an immediate expense.
- How do you interpret employee service share based compensation allocation of recognized period costs capitalized amount?
- An increase suggests more internal development activity or higher capitalization of labor, while a decrease indicates more costs are being expensed as incurred.
- How does employee service share based compensation allocation of recognized period costs capitalized amount compare across companies?
- Common in R&D-heavy firms or companies with significant internal software or infrastructure development.